Skip to main content

Table 1 Absolute and percentage values of the seven clinical signs considered

From: Nephrolithiasis, kidney failure and bone disorders in Dent disease patients with and without CLCN5 mutations

 

Total patients

Group I

Group II

Group III

Number

%

Number

%

Number

%

Number

%

Males

64

 

41

 

17

 

6

 

Median age

16 ± 12

 

14 ± 9

 

18 ± 16

 

27 ± 16

 

Range

1–58 years

 

1–43 years

 

2–58 years

 

2–46 years

 

LMWP

63

98.4

41

100

17

100

5

83.3

Nephrocalcinosis

46

71.9

36

87.8*§

7

41.2

3

50

Nepholithiasis

19

29.7

11

26.8

5

29.4

3

50

Hypercalciuria

55

85.9

40

97.6**§§

12

70.6

3

50

Phosphaturic tubulopathy

26

40.6

13

31.7

9

52.9

4

66.7

Bone disorders

22

34.4

17

41.5

5

29.4

0

0

Kidney failure

9

14.1

5

12.2

4

23.5

0

0

  1. Group I versus Group II: * p < 0.001, ** p < 0.01. Group I versus Group III: § p = 0.05, §§ p < 0.01